Retour sur lavenir.net
   ACKERMANS V.HAAREN 266.600 € (-2,70 %)     AEDIFICA 69.150 € (-1,36 %)     CMB.TECH 13.620 € (+2,41 %)     LOTUS BAKERIES 11 240.000 € (-1,40 %)     TINC 11.180 € (-0,71 %)     HYLORIS 4.410 € (+0,68 %)     RECTICEL 11.040 € (-2,99 %)     FLUXYS BELGIUM D 19.500 € (-0,51 %)     BANQUP GROUP 2.020 € (-3,81 %)     TITAN S.A. 49.460 € (-3,21 %)     ASCENCIO 51.700 € (-0,19 %)     VAN DE VELDE 29.900 € (-0,33 %)     DEME GROUP 168.000 € (-2,78 %)     INCLUSIO SA/NV 16.600 € (-1,19 %)     PROXIMUS 5.870 € (+0,69 %)     AGFA-GEVAERT 0.418 € (-0,60 %)     ELIA GROUP 136.300 € (-0,94 %)     KINEPOLIS GROUP 35.650 € (-1,38 %)     MELEXIS 74.000 € (+1,79 %)     XIOR 27.100 € (-0,55 %)     IBA 16.500 € (-2,48 %)     FAGRON 23.800 € (-1,04 %)     TESSENDERLO 19.800 € (-2,22 %)     VGP 81.800 € (-4,88 %)     GIMV 44.650 € (-1,65 %)     DECEUNINCK 2.230 € (-1,55 %)     RETAIL ESTATES 68.000 € (-2,30 %)     CAMPINE 214.000 € (+1,90 %)     UMICORE 19.760 € (-2,95 %)     TUBIZE-FIN 214.800 € (-0,74 %)     SOLVAC NOM(RETAIL) 73.500 € (+0,68 %)     SYENSQO 64.750 € (-2,63 %)     NYXOAH 1.508 € (+3,86 %)     AGEAS 70.900 € (+0,35 %)     WERELDHAVE BELGIUM 52.800 € (-1,12 %)     AB INBEV 69.720 € (-1,22 %)     VASTNED 29.350 € (-1,01 %)     AZELIS GROUP 9.950 € (+0,66 %)     COLRUYT 36.520 € (-0,65 %)     UCB 248.700 € (-2,01 %)     ACCENTIS 0.026 € (-1,89 %)     BQUE NAT. BELGIQUE 370.000 € (+2,21 %)     ARGENX SE 799.800 € (-1,53 %)     MONTEA 66.000 € (-2,22 %)     VIOHALCO 17.920 € (-5,68 %)     D'IETEREN GROUP 170.700 € (-3,99 %)     WDP 21.740 € (-2,25 %)     ECONOCOM GROUP 1.430 € (-1,72 %)     KBC ANCORA 81.800 € (-2,15 %)     BARCO 8.385 € (-1,58 %)     ROULARTA 12.900 € (-0,77 %)     ENERGYVISION 14.820 € (-0,27 %)     HOME INVEST BE. 18.940 € (-2,17 %)     BPOST 1.600 € (-2,68 %)     SOLVAY 25.900 € (-1,22 %)     ONTEX GROUP 2.300 € (-3,36 %)     BIOTALYS 3.035 € (+0,50 %)     GBL 78.100 € (-0,45 %)     ONWARD MEDICAL 2.445 € (-3,36 %)     SOFINA 224.400 € (-1,67 %)  
   TIKEHAU CAPITAL 16.880 € (-1,29 %)     SCHNEIDER ELECTRIC 263.800 € (-1,57 %)     SOCIETE GENERALE 71.300 € (-5,79 %)     ABN AMRO BANK N.V. 37.820 € (-1,74 %)     ASML HOLDING 1 529.000 € (+1,27 %)     STMICROELECTRONICS 58.490 € (+0,33 %)     PERNOD RICARD 64.160 € (-2,61 %)     SBM OFFSHORE 32.780 € (+4,20 %)     ORANGE 15.950 € (+0,19 %)     UBISOFT ENTERTAIN 5.850 € (-2,76 %)     VEOLIA ENVIRON. 36.700 € (-0,84 %)     2CRSI 32.420 € (-10,93 %)     SODEXO 54.100 € (+1,31 %)     AIR FRANCE -KLM 12.840 € (-6,55 %)     METAVISIO 0.001 € (0,00 %)     LEGRAND 142.150 € (+0,28 %)     CEGEDIM 10.500 € (+0,19 %)     ABIVAX 122.100 € (-3,71 %)     THALES 233.700 € (-1,64 %)     WOLTERS KLUWER 59.020 € (-1,93 %)     DASSAULT AVIATION 297.200 € (-2,17 %)     TOTALENERGIES 69.350 € (+2,32 %)     ATOS GROUP 32.800 € (-4,65 %)     BENETEAU 5.990 € (-2,44 %)     LVMH 484.900 € (-2,20 %)     CREDIT AGRICOLE 17.200 € (-2,27 %)     NN GROUP 76.240 € (+0,18 %)     SHELL PLC 36.150 € (+2,48 %)     S.E.B. 48.520 € (-0,98 %)     VIVORYON 1.260 € (+7,69 %)     SOPRA STERIA GROUP 148.900 € (-2,04 %)     KERLINK 1.260 € (-3,08 %)     WORLDLINE 10.054 € (-3,35 %)     ACCOR 48.190 € (-3,50 %)     HYDROGEN REFUELING 1.410 € (+6,17 %)     VALEO 12.180 € (-5,54 %)     UNILEVER 54.450 € (-1,07 %)     HAFFNER ENERGY 0.241 € (+4,57 %)     FORVIA 8.760 € (-3,01 %)     MICHELIN 34.220 € (-2,37 %)     AALBERTS NV 38.840 € (-1,22 %)     SES 7.875 € (+1,42 %)     OCI 4.088 € (+0,20 %)     L'OREAL 380.750 € (-1,96 %)     TKH GROUP 42.180 € (-1,13 %)     TRIGANO 142.300 € (-2,06 %)     JCDECAUX 20.660 € (-0,19 %)     EIFFAGE 119.050 € (-4,11 %)     AHOLD DEL 36.060 € (-0,74 %)     KLEPIERRE 35.560 € (-1,17 %)     PLANISWARE 20.450 € (-3,08 %)     FUGRO 9.835 € (+3,69 %)     AIR LIQUIDE 173.680 € (-2,53 %)     ASM INTERNATIONAL 889.800 € (-0,76 %)     ARCELORMITTAL SA 53.600 € (-4,49 %)     EXOSENS 59.300 € (-0,17 %)     ARCADIS 33.980 € (-0,35 %)     CVC CAPITAL 13.050 € (-2,68 %)     VALERIO TX 0.455 € (-1,09 %)     PROSUS 40.395 € (+2,77 %)  
News Réglementées
11/06/2026 14:30

Original-Research: DN Group AG (von GBC AG): Buy

Original-Research: DN Group AG - from GBC AG

11.06.2026 / 14:30 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of GBC AG to DN Group AG

Company Name:DN Group AG
ISIN:DE000A3DW408
 
Reason for the research:Research study (Anno)
Recommendation:Buy
Target price:EUR 6,90
Target price on sight of:31.12.2026
Last rating change:
Analyst:Cosmin Filker, Marcel Goldmann

Further expansion of the investment portfolio implemented, sig-nificant improvement in earnings achieved, rating BUY

DN Group AG sees itself as an impact investing company, focusing on investments in sectors of the future. The company has identified companies primarily in the fields of AI, mobility, the circular economy, food, health and energy as such sectors. As part of the corporate strategy, investments are made in line with this investment focus and based on the proprietary Venture Impact Assessment process, and companies are supported in their capital market activities.

Based on its carrying amount, More Impact AG is currently the most significant investment. The company describes itself as a listed “high-tech medical hub” and focuses on product innovation and strategic investments in the medical sector. Key assets include BG Braingate Technology GmbH, with its patented cigarette preparation device Z-Boxx for reducing the intake of harmful substances and nicotine consumption, as well as M-Boxx for medical cannabis. In addition, the subsidiary The Key Unternehmensberatung GmbH is developing the needle-free injection technology Speedinject, which is particularly significant for patients with a fear of needles or who require regular injections.

DN Group AG acquired approximately 25% of the shares in Algene Holding SE at the end of 2025. The purchase price of €105 million was settled through a share swap involving the transfer of 30 million More-Impact shares. Algene produces high-purity microalgae as a sustainable raw material base for the food, cosmetics, pharmaceutical and other sectors. The company uses a patented, closed production system characterised by high productivity, continuous manufacturing and GMP-Cosmetics certified quality.

In September 2025, DN Group AG carried out a capital increase in return for a contribution in kind of 88% of the shares in EcoMotion Holding AG. EcoMotion possesses patented automated parking and car park technology. By eliminating traditional infrastructure such as ramps, manoeuvring areas and stairwells, space efficiency is significantly increased. Target customers include, among others, property developers, logistics companies, car park operators and property owners.

In the past financial year 2025, DN Group AG recorded a decline in total revenue to €47.52 million (previous year: €204.45 million). At the same time, the company achieved an increase in profit after tax to €23.10 million (previous year: €20.19 million). This was primarily due to valuation gains from the More Impact investment in connection with the Algene acquisition, as well as significant consultancy revenues of €2.51 million for the first time. At the same time, other operating expenses fell significantly to €10.88 million, as, unlike in the previous year, there were no significant accounting losses.

We have determined the fair value of DN Group AG using a net asset value (NAV) approach. Net asset value (NAV), or net asset value, represents the economic equity resulting from the market values of the assets less liabilities. As at 31 December 2025, investments in associates amounted to €412.72 million (31 December 2024: €280.93 million), making them by far the company’s largest asset item. Adding the other assets and deducting interest-bearing liabilities and overhead costs, we have calculated a total NAV of €383.63 million. This equates to €6.90 per share, which is why we assign a “BUY” rating.



You can download the research here: 20260611_DN_Anno_engl

Contact for questions:
GBC AG
Halderstraße 27
86150 Augsburg
0821 / 241133 0
research@gbc-ag.de

++++++++++++++++

Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR
Beim oben analysierten Unternehmen ist folgender möglicher
Interessenkonflikt gegeben: (5a,11); Einen Katalog möglicher
Interessenkonflikte finden Sie unter: http://www.gbc-ag.de/de/Offenlegung

+++++++++++++++
Completion: 11.06.2026 (11:05 am)
First release: 11.06.2026 (2:30 pm)


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2344294  11.06.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière